EZH2 and neoplasm: Therefore, it would be interesting to target redundant epigenetic repressive marks (such as DNA methylation, H3K9 di- and tri-methylation), or the absence of activation marks, such as H3K4 tri-methylation or H3K27 acetylation (H3K27ac), to sensitize tumor cells to EZH2 inhibition.